Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Open accessAbstract
The effect of significant weight loss on nonalcoholic fatty liver disease remains unclear. In this case series of 36 selected obese patients, we examined the effect of weight loss on nonalcoholic fatty liver disease, including nonalcoholic steatohepatitis (NASH) and hepatic fibrosis. These 36 patients (11 males, 25 females) had paired liver biopsies, the first at the time of laparoscopic adjustable gastric band placement and the second after weight loss. Second biopsies were obtained from two groups: those requiring a subsequent laparoscopic procedure (n = 19) and those with index biopsy score of 2 or greater for zone 3-centric hepatic fibrosis (n = 17). All biopsies were scored, blinded to the patient's identity and clinical condition, for individual histological features and for NASH stage and grade. Initial biopsies demonstrated NASH in 23 patients and steatosis in 12 patients. Repeat biopsies were taken at 25.6 ± 10 months (range, 9-51 months) after band placement. Mean weight loss was 34.0 ± 17 kg, and percentage of excess weight loss was 52 ± 17%. There were major improvements in lobular steatosis, necroinflammatory changes, and fibrosis at the second biopsy ( P < .001 for all). Portal abnormalities remained unchanged. Only four of the repeat biopsies fulfilled the criteria for NASH. There were 18 patients with an initial fibrosis score of 2 or more compared with 3 patients at follow-up ( P < .001). Those with the metabolic syndrome (n = 23) had more extensive changes before surgery and greater improvement with weight loss. In conclusion , weight loss after surgery provides major improvement or resolution of obesity and metabolic syndrome-associated abnormal liver histological features in severely obese subjects. (Hepatology 2004;39:1647-1654.)
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In 36 adults with paired liver biopsies approximately 2 years after AGB, nearly all showed major reductions in lobular steatosis, inflammation, and fibrosis (p < 0.001).
“In a seminal biopsy study by Dixon et al., 36 adults underwent paired liver biopsies at ~2 years after AGB: nearly all showed major reductions in lobular steatosis, inflammation, and fibrosis (p < 0.001).”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [45]
The Results report 36 paired biopsies obtained an average of 25.6 months after gastric banding; Table 4 shows significant improvements in steatosis, lobular inflammation, and fibrosis scores (all p < 0.001). But these are group-level findings, not evidence that nearly every patient had major reductions in all three features. The NASH Grade and Stage section reports that 70% of patients with fibrosis at baseline had none at follow-up. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe proportion of AGB patients meeting NASH criteria fell from 64% pre-operatively to approximately 11% at follow-up.
“The proportion meeting NASH criteria fell from 64% pre-operatively to ~11% on follow-up”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [45]
The number of AGB patients with significant fibrosis (stage ≥ 2) dropped from 18 to three (p < 0.001).
“and the number of patients with significant fibrosis (stage ≥ 2) dropped from 18 to three (p < 0.001) [45].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [45]
Clinical interventions such as weight loss from dietary changes, bariatric surgery, pharmacological agents, or FXR agonists are associated with fibrosis regression in MASH.
“Clinical interventions such as weight loss resulting from dietary changes, bariatric surgery, pharmacological agents, or the use of farnesoid X receptor (FXR) agonists have been associated with fibrosis regression in patients with MASH (256-258).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [257]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · see citing works
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · see citing works
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,155 · see citing works
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Lévy, J., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 1,997 · see citing works
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,365 · see citing works
Self-citationLLUSIA, J. B. (1983) · PubMed · Cited by 1,286 · see citing works
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 926 · see citing works
Neuschwander‐Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1053/jhep.2003.50420 · Cited by 749 · see citing works
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D. M., Whitehall, V., Shorthouse, C., Clouston, A. D., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 673 · see citing works
Excess weight risk factor for alcoholic liver disease
Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., & Chaput, J. (1997) · Hepatology · doi:10.1002/hep.510250120 · Cited by 666 · see citing works
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 608 · see citing works
Laparoscopic adjustable gastric banding in the treatment of obesity: A systematic literature review
Chapman, A. (2004) · Surgery · doi:10.1016/s0039-6060(03)00392-1 · Cited by 529 · see citing works
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A. J., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 487 · see citing works
Hepatic effects of dietary weight loss in morbidly obese subjects
Andersen, T., Gluud, C. N., Franzmann, M., & Christoffersen, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90942-5 · Cited by 405 · see citing works
O’Brien, P. E., Dixon, J. B., Brown, W. A., Schachter, L. M., Chapman, L., Burn, A. J., Dixon, M. E., Scheinkestel, C. D., Halket, C., Sutherland, L. J., et al. (2002) · Obesity Surgery · doi:10.1381/096089202321019639 · Cited by 380 · see citing works
Self-citationEffects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322 · see citing works
Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C
Hickman, I. J., Clouston, A. D., Macdonald, G. A., Purdie, D. M., Prins, J. B., Ash, S., Jonsson, J. R., & Powell, E. E. (2002) · Gut · doi:10.1136/gut.51.1.89 · Cited by 301 · see citing works
Drenick, E. J., Simmons, F. A., & Murphy, J. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197004092821502 · Cited by 287 · see citing works
Zein, N. N., Abdulkarim, A. S., Wiesner, R. H., Egan, K. S., & Persing, D. H. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80065-3 · Cited by 257 · see citing works
Chronic hepatitis C and superimposed nonalcoholic fatty liver disease
Ong, J. P., Younossi, Z. M., Speer, C. A., Olano, A., Gramlich, T., & Boparai, N. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021004266.x · Cited by 152 · see citing works
Intestinal Bypass Surgery for Morbid Obesity: Long-Term Results
DeWind, L. T., & Payne, J. H. (2014) · JAMA · doi:10.1001/jama.2014.10853 · Cited by 118 · see citing works
Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler
Lee, R. G. (1995) · Hepatology · doi:10.1002/hep.1840210636 · Cited by 96 · see citing works
New classification and criteria for diagnosis of diabetes mellitus
Colman, P. G., Thomas, D. W., Zimmet, P., Welborn, T. A., Garcia‐Webb, P., & Moore, M. P. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb139171.x · Cited by 95 · see citing works
Hostophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver
James, J., Bosch, K. S., Zuyderhoudt, F. M. J., Houtkooper, J. M., & Gool, J. V. (1986) · Histochemistry and Cell Biology · doi:10.1007/bf00491759 · Cited by 91 · see citing works
Intestinal Bypass Surgery for Morbid Obesity
DeWind, L. T. (1976) · JAMA · doi:10.1001/jama.1976.03270210024017 · Cited by 83 · see citing works
Tulachan, S., Doi, R., Kawaguchi, Y., Tsuji, S., Nakajima, S., Masui, T., Koizumi, M., Toyoda, E., Mori, T., Ito, D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.1.76 · Cited by 78 · see citing works
Effect of weight control on hepatic abnormalities in obese patients with fatty liver
Park, H. S., Kim, M. W., & Shin, E. S. (1995) · Journal of Korean Medical Science · doi:10.3346/jkms.1995.10.6.414 · Cited by 75 · see citing works
The Gastric Bypass for Failed Bariatric Surgical Procedures
Fox, S. R., Fox, K. M., & Oh, K. H. (1996) · Obesity Surgery · doi:10.1381/096089296765557097 · Cited by 43 · see citing works
Hepatic Complications of Jejunoileal Bypass
O'Leary, J. (1983) · Seminars in Liver Disease · doi:10.1055/s-2008-1040686 · Cited by 28 · see citing works
Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease.
Vyberg, M., & Leth, P. M. (1991) · PubMed · Cited by 24 · see citing works
Prevention and Reversal of Liver Damage following Biliopancreatic Diversion for Obesity
Antal, S. C. (1994) · Obesity Surgery · doi:10.1381/096089294765558520 · Cited by 23 · see citing works
Kleiner, D. E., Brunt, E. M., VANNATTA, M., Behling, C. A., Contos, M. J., Cummings, O. W., Ferrell, L. D., LIU, Y., Torbenson, M. S., & Yeh, M. (2003) · Hepatology · doi:10.1016/s0270-9139(03)80203-3 · Cited by 19 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [20]20. Freedman R, Uwaifo GI, Lutchman G, Promrat K, Kleiner D, Yanovski JA, et al. Changes in insulin sensitivity and improvements in liver histology in patients with non-alcoholic steatohepatitis (NASH) treated with Piogli- tozone. Diabetes 2003;52:A76.
Cited by
Sorted by citations
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958 · see citing works
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,413 · see citing works
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · see citing works
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · see citing works
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez‐Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058 · see citing works
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762 · see citing works
Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721 · see citing works
Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 683 · see citing works
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674 · see citing works
Magnetic resonance elastography of liver: Technique, analysis, and clinical applications
Venkatesh, S. K., Yin, M., & Ehman, R. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23731 · Cited by 661 · see citing works
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625 · see citing works
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603 · see citing works
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569 · see citing works
Ahrens, M., Ammerpohl, O., von Schönfels, W., Kolarova, J., Bens, S., Itzel, T., Teufel, A., Herrmann, A., Brosch, M., Hinrichsen, H., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.07.004 · Cited by 528 · see citing works
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al‐Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 551 · see citing works
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Targher, G., & Arcaro, G. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551 · see citing works
Zelber‐Sagi, S., Nitzan, D., Goldsmith, R., Webb, M., Blendis, L. M., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 545 · see citing works
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515 · see citing works
Tolman, K. G., Fonseca, V. A., Dalpiaz, A. S., & Tan, M. H. (2007) · Diabetes Care · doi:10.2337/dc06-1539 · Cited by 527 · see citing works
THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment
Reaven, G. M. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132155 · Cited by 516 · see citing works
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511 · see citing works
Harnois, D. M. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505 · see citing works
Kim, I. H., Kisseleva, T., & Brenner, D. A. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000176 · Cited by 499 · see citing works
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.012 · Cited by 482 · see citing works
Self-citationMathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R. J., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483 · see citing works
Harrison, S. A., Fecht, W., Brunt, E. M., & Neuschwander‐Tetri, B. A. (2009) · Hepatology · doi:10.1002/hep.22575 · Cited by 470 · see citing works
Pathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 471 · see citing works
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
Gadd, V. L., Skoien, R., Powell, E. E., Fagan, K. J., Winterford, C., Horsfall, L., Irvine, K., & Clouston, A. D. (2014) · Hepatology · doi:10.1002/hep.26937 · Cited by 452 · see citing works
Hepatic Stellate Cells and Liver Fibrosis
Moreira, R. K. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-1728-hscalf · Cited by 452 · see citing works
Histopathology of nonalcoholic fatty liver disease
Brunt, E. M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i42.5286 · Cited by 448 · see citing works
Chen, J., Talwalkar, J. A., Yin, M., Glaser, K. J., Sanderson, S. O., & Ehman, R. L. (2011) · Radiology · doi:10.1148/radiol.11101942 · Cited by 434 · see citing works
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 440 · see citing works
Nonalcoholic fatty liver disease and the metabolic syndrome
Marchesini, G., Marzocchi, R., Agostini, F., & Bugianesi, E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174153.53683.f2 · Cited by 420 · see citing works
Clinical evidence for the regression of liver fibrosis
Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411 · see citing works
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.
Haas, J., Francque, S., & Staels, B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 372 · see citing works
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD)
Brunt, E. M., Kleiner, D. E., Wilson, L., Ünalp, A., Behling, C. A., Lavine, J. E., & Neuschwander‐Tetri, B. A. (2008) · Hepatology · doi:10.1002/hep.22724 · Cited by 388 · see citing works
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 388 · see citing works
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. T. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 384 · see citing works
Reversal of Hepatic Fibrosis — Fact or Fantasy?
Friedman, S. L., & Bansal, M. B. (2006) · Hepatology · doi:10.1002/hep.20974 · Cited by 377 · see citing works
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L. W., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 379 · see citing works
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., González-Campoy, J. M., Collazo–Clavell, M. L., Guven, S., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R. E., et al. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.08.009 · Cited by 372 · see citing works
Self-citationLee, Y., Doumouras, A. G., Yu, J., Brar, K., Banfield, L., Gmora, S., Anvari, M., & Hong, D. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.017 · Cited by 371 · see citing works
Younossi, Z. M., Loomba, R. S., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander‐Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., et al. (2017) · Hepatology · doi:10.1002/hep.29724 · Cited by 361 · see citing works
Friedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350 · see citing works
Treatment of non-alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.042200 · Cited by 349 · see citing works
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., González-Campoy, J. M., Collazo–Clavell, M. L., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R. E., Sarwer, D. B., et al. (2009) · Obesity · doi:10.1038/oby.2009.28 · Cited by 338 · see citing works
Self-citationMattar, S. G., Velcu, L. M., Rabinovitz, M., Demetris, A. J., Krasinskas, A. M., Barinas‐Mitchell, E., Eid, G. M., Ramanathan, R. C., Taylor, D. S., & Schauer, P. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179652.07502.3f · Cited by 341 · see citing works
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340 · see citing works
Poirier, P., Cornier, M.-A., Mazzone, T., Stiles, S., Cummings, S., Klein, S., McCullough, P. A., Ren Fielding, C., & Franklin, B. A. (2011) · Circulation · doi:10.1161/cir.0b013e3182149099 · Cited by 339 · see citing works
Recent concepts in non‐alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01748.x · Cited by 324 · see citing works
Pathophysiology of nonalcoholic steatohepatitis.
McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 317 · see citing works
Zelber–Sagi, S., Kessler, A., Brazowsky, E., Webb, M., Lurie, Y., Santo, M., Leshno, M., Blendis, L., Halpern, Z., & Oren, R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.004 · Cited by 317 · see citing works
Colles, S. L., Dixon, J. B., Marks, P., Strauss, B. J., & O’Brien, P. E. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.304 · Cited by 317 · see citing works
Self-citationDe novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
Eissing, L., Scherer, T., Tödter, K., Knippschild, U., Greve, J. W. M., Buurman, W. A., Pinnschmidt, H. O., Rensen, S. S., Wolf, A. M., Bartelt, A., et al. (2013) · Nature Communications · doi:10.1038/ncomms2537 · Cited by 302 · see citing works
Kleiner, D. E., & Makhlouf, H. R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.011 · Cited by 303 · see citing works
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
Zelber‐Sagi, S. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i29.3377 · Cited by 299 · see citing works
Colles, S. L., Dixon, J. B., Marks, P., Strauss, B. J., & O’Brien, P. E. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.304 · Cited by 361 · see citing works
Self-citationOxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis
Grattagliano, I., Palmieri, V. O., Portincasa, P., Moschetta, A., & Palasciano, G. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.06.011 · Cited by 296 · see citing works
Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Zvibel, I., Goldiner, I., Blendis, L., Halpern, Z., & Oren, R. (2008) · Hepatology · doi:10.1002/hep.22525 · Cited by 296 · see citing works
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Chávez-Tapia, N. C., Téllez-Ávila, F. I., Barrientos‐Gutiérrez, T., Méndez‐Sánchez, N., Lizardi-Cervera, J., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007340.pub2 · Cited by 296 · see citing works
Histological assessment of non‐alcoholic fatty liver disease
Hübscher, S. G. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02416.x · Cited by 292 · see citing works
Preiss, D., & Sattar, N. A. (2008) · Clinical Science · doi:10.1042/cs20070402 · Cited by 292 · see citing works
Nonalcoholic Fatty Liver Disease
Adams, L. A., & Lindor, K. D. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.05.013 · Cited by 290 · see citing works
Klein, S., Mittendorfer, B., Eagon, J. C., Patterson, B. W., Grant, L. M., Feirt, N. M., Seki, E., Brenner, D. A., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 288 · see citing works
Cirrhosis and its complications: Evidence based treatment
Nusrat, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5442 · Cited by 284 · see citing works
Roles of PPARs in NAFLD: Potential therapeutic targets
Tailleux, A., Wouters, K., & Staels, B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.016 · Cited by 283 · see citing works
Safadi, R., Konikoff, F. M., Mahamid, M., Zelber‐Sagi, S., Halpern, M., Gilat, T., Oren, R., Safadi, R., Konikoff, F. M., Hershkovitz, A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.038 · Cited by 275 · see citing works
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Calvente, C. J., Tameda, M., Johnson, C. D., del Pilar, H., Lin, Y. C., Adronikou, N., De Mollerat Du Jeu, X., Llorente, C., Boyer, J., & Feldstein, A. E. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122258 · Cited by 268 · see citing works
Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
Torres, D. M., Williams, C. D., & Harrison, S. A. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.03.011 · Cited by 269 · see citing works
Pathogenesis and management issues for non-alcoholic fatty liver disease
Duvnjak, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i34.4539 · Cited by 265 · see citing works
Current efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z. D., & Sanyal, A. J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 263 · see citing works
Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259 · see citing works
Bower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A. W., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 255 · see citing works
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 253 · see citing works
IS ALCOHOL CONSUMPTION A RISK FACTOR FOR WEIGHT GAIN AND OBESITY?
Suter, P. M., & Tremblay, A. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360590913542 · Cited by 249 · see citing works
Athyros, V. G., Mikhailidis, D. P., Didangelos, T., Γιουλεμέ, Ό., Liberopoulos, E. N., Karagiannis, A. I., Kakafika, A. I., Τζιόμαλος, Κ., Burroughs, A. K., & Elisaf, M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104696 · Cited by 248 · see citing works
Review of MR elastography applications and recent developments
Glaser, K. J., Manduca, A., & Ehman, R. L. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23597 · Cited by 246 · see citing works
Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases
Falize, L., Guillygomarc’h, A., Perrin, M., Lainé, F., Guyader, D., Brissot, P., Turlin, B., & Deugnier, Y. (2006) · Hepatology · doi:10.1002/hep.21260 · Cited by 245 · see citing works
Targher, G. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02025.x · Cited by 245 · see citing works
Cefalu, W. T., Bray, G. A., Home, P., Garvey, W. T., Klein, S., Pi-Sunyer, X., Hu, F. B., Raz, I., Gaal, L. V., Wolfe, B. M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1081 · Cited by 245 · see citing works
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G. A., Modi, A. A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M. G., Borg, B. B., Loomba, R. S., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 240 · see citing works
Benefits of lifestyle modification in NAFLD
Harrison, S. A., & Day, C. P. (2007) · Gut · doi:10.1136/gut.2006.112094 · Cited by 240 · see citing works
Pathology of fatty liver disease
Brunt, E. M. (2007) · Modern Pathology · doi:10.1038/modpathol.3800680 · Cited by 238 · see citing works
Change in Liver Size and Fat Content after Treatment with Optifast® Very Low Calorie Diet
Lewis, M. C., Phillips, M. L., Slavotinek, J., Kow, L., Thompson, C., & Toouli, J. (2006) · Obesity Surgery · doi:10.1381/096089206777346682 · Cited by 242 · see citing works
Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M., Bertolini, L., Rodella, S., Zenari, L., Lippi, G., Franchini, M., Zoppini, G., & Muggeo, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101155 · Cited by 233 · see citing works
Pinzani, M., Rosselli, M., & Zuckermann, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.009 · Cited by 228 · see citing works
Excess body weight: Novel insights into its roles in obesity comorbidities
Zhang, X., Ha, S., Lau, H. C.-H., & Yu, J. Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.008 · Cited by 242 · see citing works
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 226 · see citing works
Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery
Barker, K. B., Palekar, N. A., Bowers, S. P., Goldberg, J. E., Pulcini, J. P., & Harrison, S. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00419.x · Cited by 218 · see citing works
Bariatric surgery: Mechanisms, indications and outcomes
O’Brien, P. E. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06391.x · Cited by 214 · see citing works
Self-citationDixon, J., Bhathal, P., & O'Brien, P. (2006) · Obesity Surgery · doi:10.1381/096089206778663805 · Cited by 212 · see citing works
Self-citationJazayeri-Tehrani, S. A., Rezayat, S. M., Mansouri, S., Qorbani, M., Alavian, S. M., Daneshi‐Maskooni, M., & Hosseinzadeh‐Attar, M. J. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0331-1 · Cited by 212 · see citing works
Setji, T. L., Holland, N. D., Sanders, L. L., Pereira, K. C., Diehl, A. M., & Brown, A. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2774 · Cited by 210 · see citing works
Bataller, R. A., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282 · Cited by 5,087 · see citing works
Liver Disease in Patients With Diabetes Mellitus
Harrison, S. A. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000190774.91875.d2 · Cited by 197 · see citing works
Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?
Bonekamp, S., Kamel, I. R., Solga, S. F., & Clark, J. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.016 · Cited by 193 · see citing works
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J. M., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 193 · see citing works
Non-alcoholic steatohepatitis: From cell biology to clinical practice
Cortez‐Pinto, H., de Moura, M. C., & Day, C. P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.002 · Cited by 193 · see citing works
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., González-Campoy, J. M., Collazo–Clavell, M. L., Guven, S., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R. E., et al. (2008) · Endocrine Practice · doi:10.4158/ep.14.s1.1 · Cited by 193 · see citing works
Self-citation
- Authors
- Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Dixon, John B.
- ORCID
- Dixon, John B.
- Venue
- Hepatology
- Published
- 2004-06
- Volume
- 39
- Issue
- 6
- Pages
- 1647-1654
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2063671857
- Cited by
- 727
- References
- 35
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 19 · 2021: 27 · 2020: 20 · 2019: 31 · 2018: 26 · 2017: 36 · 2016: 32 · 2015: 44 · 2014: 33 · 2013: 38 · 2012: 38
- FWCI
- 40.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, liver fibrosis, weight loss, laparoscopic adjustable gastric band, bariatric surgery, obesity, metabolic syndrome, liver histopathology, steatosis, necroinflammation
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Male, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
